دورية أكاديمية

Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?

التفاصيل البيبلوغرافية
العنوان: Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?
المؤلفون: Tenni, Brigitte, Lexchin, Joel, Phin, Sovath, Gleeson, Deborah
المصدر: International Journal of Social Determinants of Health & Health Services; Jul2024, Vol. 54 Issue 3, p295-308, 14p
مصطلحات موضوعية: INTELLECTUAL property, MIDDLE-income countries, DARUNAVIR, COST effectiveness, DEVELOPED countries, LOPINAVIR-ritonavir, HIV infections, ANTI-HIV agents, HEPATITIS C, PATENTS, LOW-income countries
مصطلحات جغرافية: CAMBODIA
مستخلص: Cambodia has experienced exponential economic growth in recent years and is expected to graduate from least developed country (LDC) status within the next decade. Membership of the World Trade Organization (WTO) will require Cambodia to grant product and process patents for pharmaceuticals upon LDC graduation. This study aims to measure the impact of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on the price of HIV and hepatitis C medicine in Cambodia once it graduates from LDC status and is obliged to make patents available for pharmaceutical products and processes. Using scenarios based on likely outcomes of accession to the TRIPS Agreement, it measures the impact on the price of the HIV treatment program and compares that impact with the hepatitis C treatment program. Graduation from LDC status would be expected to result in a modest increase in the cost of the antiretroviral (ARV) treatment program and very large increases in the cost of the direct acting antivirals (DAA) treatment program. If annual treatment budgets remain constant, patent protection could see 1,515 fewer people living with HIV able to access ARV treatment and 2,577 fewer people able to access DAA treatment (a drop in treatment coverage of 93%). [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Social Determinants of Health & Health Services is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:27551938
DOI:10.1177/27551938241242602